医薬品安全性情報 Vol.6 No.04 2008/02/21
医薬品安全性情報Vol.6 No.04(2008/02/21) 3 表は,この研究1) で他のクラスの降圧薬によるリスク増加が確認されなかったことも示しているが,
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
NIHS 医薬品安全性情報 Vol.16 No.012018/0111/
www.nihs.go.jpCarafate’]の製品表示が改訂され, 販売名が[‘Carafate suspension’]から [‘Carafate oral suspension’]に変更さ
Guideline for the Development of Liposome Drug …
www.nihs.go.jp4 described in this document are also subject to other relevant notifications and guidelines. The active substances mentioned here include a low-molecular-weight chemical entity, a
Guideline for Bioequivalence Studies of Generic …
www.nihs.go.jp1 Guideline for Bioequivalence Studies of Generic Products for Topical Use July 7, 2003 局所皮膚適用製剤の後発医薬品のための 生物学的同等性試験ガイドライン
Since 1874 遺伝子治療用製品の開発における 国内 …
www.nihs.go.jp遺伝子治療の現状 海外の遺伝子治療の規制と国際調和 日本の遺伝子治療と関連規制 遺伝子治療指針の改正
Guideline for Bioequivalence Studies for Different ...
www.nihs.go.jp2 Section 1: Introduction This guideline describes the principles of procedures of bioequivalence studies for oral solid dosage forms that contains a different quantity of the active ingredient from an
Guidelines, Studies, Solid, Dosage, Guideline for bioequivalence studies for, Bioequivalence, Solid dosage
Clinical Pharmacokinetic Studies of Pharmaceuticals
www.nihs.go.jp- 1 - Clinical Pharmacokinetic Studies of Pharmaceuticals This document is an informal translation of the official text that was promulgated in Japanese on
Pharmaceutical, Clinical, Studies, Clinical pharmacokinetic studies of pharmaceuticals, Pharmacokinetic
平成 25 年度報告 毒物劇物指定の ... - nihs.go.jp
www.nihs.go.jp平成. 25 年度報告 毒物劇物指定のための有害性情報の収集・評価. 物質名: n-(2-
毒物及び劇物取締法Q&A - nihs.go.jp
www.nihs.go.jp1 平成29年3月31日更新 毒物及び劇物取締法Q&A 質問一覧 1.毒物及び劇物取締法について ..... 4
European Medicines Agency - NIHS
www.nihs.go.jpWhat is Quality Risk Management? • Proposed ICH Q9 definition: “Quality risk management is a systematic process for the identification, assessment
Management, European, Quality, Risks, Agency, Quality risk management, Medicine, European medicines agency, Nihs, Ich q9
ICH Q9 ‘Quality Risk Management’ - NIHS
www.nihs.go.jpICH Q9 ‘Quality Risk Management’ - an industry view Peter H. Gough, Eli Lilly and Company
Management, Quality, Risks, Nihs, Ich q9 quality risk management nihs, Ich q9 quality risk management
Related documents
SEZNAM MONOGRAFIJ UČINKOVIN IN POMOžNIH …
www.formularium.si188 FORMULARIUM SLOVENICUM 3.0 VII. S EZNAM MONOGRAFIJ Latinsko ime Slovensko ime Monografija Farmakopeja Acidum trichloraceticum triklorocetna kislina Trichloroacetic acid (1967) Ph.Eur.
Pharmacopeial Forum Vol. 35(5) [Sept.–Oct. 2009] …
www.nihs.go.jpChange to read: Heparin Sodium.DEFINITION Heparin Sodium is the sodium salt of sulfated glycosami-noglycans present as a mixture of heterogeneous molecules
EMOLLIENTS - Wandsworth CCG
www.wandsworthccg.nhs.uk*Acknowledgement: Nicola Watts, Medicines Information Pharmacist, Wessex Drug & Medicines Information Centre, prepared for National Eczema Week 18th th– 25 September 2010, August 2010.
Guidelines for Drinking-Water Quality - Second …
www.who.intPreface In 1984 and 1985, the World Health Organization (WHO) published the first edition of Guidelines for drinking-water quality in three volumes.The development of these guidelines was organized
Health, Guidelines, Quality, World health organization, World, Organization, Water, Drinking, Guidelines for drinking water quality
Appendix 2.2 - Drinking Water Quality Standard …
www.epd.gov.hkAppendix 2.2 - Drinking Water Quality Standard Table 1 - Chemicals of Health Significance as described by World Health Organization Guidelines